{"id":"W4389728363","doi":"10.1001/jamaoncol.2023.5410","title":"Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Carboplatin; Bevacizumab; Internal medicine; Oncology; Pembrolizumab; Population; Chemoradiotherapy; Chemotherapy; Pemetrexed; Response Evaluation Criteria in Solid Tumors; Cancer; Surgery; Cisplatin; Phases of clinical research; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00203553,0.0009913344,0.002277285,0.0005723393,0.0002689758,0.0008879242,0.0006421678,0.001015276,0.006275874],"category_scores_gemma":[0.002518297,0.0004087685,0.002723751,0.0005250603,0.000559895,0.0008277927,0.000364762,0.00145812,0.0005312731],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007002956,"about_ca_system_score_gemma":0.0008904893,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000728344,"about_ca_topic_score_gemma":0.002507067,"domain_scores_codex":[0.9989818,0.0005243897,0.000134346,0.0001550021,0.00008851786,0.0001159847],"domain_scores_gemma":[0.9994169,0.0002054274,0.0002090057,0.00005518977,0.00003224389,0.00008119034],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.949707,0.001958979,0.001011286,0.002836452,0.005341138,0.00004122874,0.00002801214,0.0003657874,0.003023731,0.0001347253,0.0009156169,0.0346362],"study_design_scores_gemma":[0.8884962,0.08930488,0.006526736,0.0003522361,0.009055951,0.00009036556,0.0000414034,0.0006093434,0.002031771,0.0004711894,0.002997439,0.00002251544],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9208143,0.05649986,0.001804619,0.001170498,0.001110549,0.008629806,0.002903838,0.0002424079,0.006824105],"genre_scores_gemma":[0.9868053,0.005958062,0.0008692449,0.0006634324,0.0002511896,0.003068959,0.000671229,0.00001217821,0.00170042],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006275874,"threshold_uncertainty_score":0.02099484,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09245552719655493,"score_gpt":0.4002722129984446,"score_spread":0.3078166858018897,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}